A supply shortage forced a medication swap for an HIV patient. Then target-shaped lesions spread across his face. A new case report, published in Cureus, looks at why early recognition can prevent something worse.

A supply shortage forced a medication swap for an HIV patient. Then target-shaped lesions spread across his face. A new case report, published in Cureus, looks at why early recognition can prevent something worse.
A survey of 26 people found 81% believe stem cells have advantages for stroke, but only 31% called them effective; most said "maybe." Published in Cureus.
A new study analyzed genomic profiles from 39 Indian cancer patients using a 1,080-gene sequencing panel. Result: 124 genetic alterations found, with nearly half clinically actionable. Published in Cureus.
A new class of Alzheimer's drugs targets the disease directly. In the UAE, only eight patients got one between 2022 and 2024. A new Cureus study looks at why.
For 130 weeks, doctors tried nearly everything for one woman's bipolar disorder. The treatment that finally worked had to stop, not from failure but from a manageable side effect.
EDs are adopting AI triage tools, trauma registries, and predictive analytics faster than the research meant to validate them. Where the evidence actually stands: blog.cureus.com/emergency-me...
A new survey of children in South India found over a third under five were stunted. Researchers say diet alone doesn't explain it; maternal health and household conditions play a role too.
Take a sudden deep breath and blood flow in your fingers briefly drops. A new Cureus review looks at this reflex and finds it's harder to interpret than it looks.
Pleural effusion is one of the most common complications after heart surgery. A new Cureus review argues the biggest overlooked lever for treating it is the diaphragm, not the heart or lungs.
Many patients are consulting AI chatbots about their mental health without telling their psychiatrist. A new Cureus review calls it "the parallel consultation" and says psychiatry hasn't caught up.
There was no epilepsy screening tool in Indonesia until now. Researchers just validated one that caught every case in testing but also flagged people who didn't have it.
[email protected] just launched a free weekly newsletter for clinicians managing neurological conditions: curated research, case studies, and policy news, every Thursday.